Daniel J. Starks, Director at ABBOTT LABORATORIES (ABT), bought 400 shares at $60.87 ($24K) on 2018-02-27, disclosed to the SEC on 2018-02-28.
Open-market purchase of $24k ABT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ABT | SELL | 2023-10-30 | $9.4M | — | Filing → |
| ABT | SELL | 2023-07-28 | $11.4M | — | Filing → |
| ABT | SELL | 2023-05-02 | $10.7M | — | Filing → |